Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome.
about
The Link between Hypersensitivity Syndrome Reaction Development and Human Herpes Virus-6 ReactivationPathogenesis and diagnosis of delayed-type drug hypersensitivity reactions, from bedside to bench and backEvolving models of the immunopathogenesis of T cell-mediated drug allergy: The role of host, pathogens, and drug response.Fever, rash, and systemic symptoms: understanding the role of virus and HLA in severe cutaneous drug allergy.DRESS syndrome: cerebral vasculitic-like presentation.Drug rash with eosinophilia and systemic symptoms syndrome induced by chloral hydrate in early childhood.HLA associations and clinical implications in T-cell mediated drug hypersensitivity reactions: an updated review.Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): An Interplay among Drugs, Viruses, and Immune System.Antiviral drug allergy.Pharmacogenetics of drug hypersensitivity.High-level human herpesvirus-6 viremia associated with onset of Stevens-Johnson syndrome: report of two cases.Drug-induced hypersensitivity syndrome by liposomal amphotericin-B: a case report.Granulomatous interstitial nephritis associated with atypical drug-induced hypersensitivity syndrome induced by carbamazepineFlare-up reactions in severe drug hypersensitivity: infection or ongoing T-cell hyperresponsivenessTreatment of DIHS/DRESS syndrome with combined N-acetylcysteine, prednisone and valganciclovir--a hypothesisCD134 is a cellular receptor specific for human herpesvirus-6B entry.Diphenylhydantoin Induced DRESS Syndrome: A Case Report.Persistent human herpesvirus-6 infection in patients with an inherited form of the virus.Activation of human herpesvirus replication by apoptosisHuman herpesvirus 6A infection and immunopathogenesis in humanized Rag2⁻/⁻ γc⁻/⁻ mice.Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) with Teicoplanin: A Case ReportNew aspects of drug-induced hypersensitivity syndrome.Pharmacogenetics of cutaneous adverse drug reactions.Chromosomally integrated human herpesvirus 6: questions and answers.Cutaneous adverse drug reactions to anti-tuberculosis drugs: state of the art and into the future.Anticonvulsant hypersensitivity syndrome: an update.HLA and pharmacogenetics of drug hypersensitivity.Drug reaction with eosinophilia and systemic symptoms: is cutaneous phenotype a prognostic marker for outcome? A review of clinicopathological features of 27 cases.Allopurinol hypersensitivity: a systematic review of all published cases, 1950-2012.Roseola infantum and its causal human herpesviruses.Crucial Role of Viral Reactivation in the Development of Severe Drug Eruptions: a Comprehensive Review.Changes in the aetiology, clinical presentation and management of acute interstitial nephritis, an increasingly common cause of acute kidney injury.Drug hypersensitivity in children: report from the pediatric task force of the EAACI Drug Allergy Interest Group.Adverse cutaneous drug eruptions: current understanding.The Role and Immunobiology of Eosinophils in the Respiratory System: a Comprehensive Review.Cutaneous Adverse Effects of Neurologic Medications.Recent advances in the understanding of severe cutaneous adverse reactions.Human herpesvirus 6 lymphadenitis in drug rash with eosinophilia and systemic symptoms syndrome: a lymphoma mimic.Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome and the Rheumatologist.Co-existence of histopathological features is characteristic in drug reaction with eosinophilia and systemic symptoms and correlates with high grades of cutaneous abnormalities.
P2860
Q21284983-9595A635-50D6-4EDC-8980-9B3150D757AAQ26784638-D5044202-47BF-4815-B7E4-2B9E91AABCA6Q26800980-DBEBE029-B164-4DFB-B4C5-4FDD29900D91Q27692095-2A332BF8-17B5-47E4-B4F3-36A4E64832C7Q30982666-1F10CB90-F545-4C32-BE9B-B78188FD9AA2Q33612261-A5BA1798-EBDA-4BE4-8697-7F19060D082FQ33666857-510C5E66-2D06-4C68-8ED5-85A78BBA1788Q33838853-F85BF8F1-C9DD-48CA-9E65-4443627D80EBQ34075812-886FDF8B-1814-4EE3-947A-8E2F3F1B928EQ34118186-89046BC6-84AE-4768-A126-5FC853E0AE65Q35411127-C1265C5B-477E-4557-8FE2-037A32529A30Q35792845-CBBDD0E2-29E6-4808-9E4A-EF05D158D8E2Q35815707-B23E9813-D800-411F-8662-C8151BE8A99CQ36188341-E187A2ED-5A51-4332-A0CB-0A65012464C2Q36577565-9966D7C2-04F0-4BC5-A59E-87D103884233Q36895490-B69833F2-5F4B-4CE0-8E77-7AFD53B822C8Q36971926-FE91A7C9-A85C-4B96-9ADF-AFA4A2D888DFQ37189313-D1131C71-C3CF-4337-BBCE-8278E1595BB5Q37252864-59633B0C-F4E6-4DBF-A5EB-2352FB9C1F97Q37254302-14C2B69E-A307-4A72-8A01-1B5964DAD46DQ37521222-F759C089-E2BB-4EA1-8A88-6263BBAE520AQ37845909-4D73E94C-56EC-4C13-958A-C0F01C45FC81Q37845914-07F6E119-A079-4179-A11A-6FE31CF2DAE7Q37952634-9EEF4599-88F5-4EC7-9C9D-BF857099D7AAQ38003494-3EDB6890-C8F6-4AB9-A438-18B92545CD51Q38026153-184F0FC0-5235-4E0C-83F5-31F04A963243Q38037649-EB3445AD-DEAD-41F3-9CAA-D876F02E7D36Q38049184-8EA7EC5C-D389-4C54-A060-523C5DB5D6BCQ38123116-8649B416-154B-48CB-A610-CC5F44BB90C8Q38199720-BD239F6A-6B78-4BB2-9691-8293DFB751DDQ38204912-E7B95202-4073-4306-977D-178F53AAF23BQ38260985-81EB3BCD-A255-46B5-B13B-66E955AAEC7BQ38594812-E44F1954-7741-47A8-A539-D0933D825DFDQ38629246-A4C90099-72D0-4B05-9C93-1783ADDA8700Q38707472-247D0CDE-8937-4484-9AEE-24BFA780E1FAQ38749921-9D5B685F-7EA9-4E94-A1CA-91D3F9061AA0Q38931289-816B7F36-AAD9-47E4-866E-4A05BAC5B8BCQ39069483-C38E5071-0CA2-4216-8614-E8740477F324Q39110729-90D7B0A6-5DD9-4A15-BC1B-F4A3F1AC0DB5Q39735938-83BE6319-4EEB-4D86-A233-47E8CFEB58E8
P2860
Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Association of human herpesvir ...... ced hypersensitivity syndrome.
@en
type
label
Association of human herpesvir ...... ced hypersensitivity syndrome.
@en
prefLabel
Association of human herpesvir ...... ced hypersensitivity syndrome.
@en
P2093
P1476
Association of human herpesvir ...... ced hypersensitivity syndrome.
@en
P2093
Hashimoto K
Horikawa T
Matsumoto K
Nakajima K
Yasukawa M
P304
P356
10.1111/J.1365-2133.2007.08167.X
P407
P577
2007-09-13T00:00:00Z